FDA Tackles Drug Competition to Improve Patient Access By Anna Jurczynska | August 3, 2017 Posted in Recent News and tagged competition, Drug Competition Action Plan, FDA, FDA Commissioner, patient access, prescription drugs, scott gottlieb, U.S. Food and Drug Administration ← EMA and the pharmaceutical industryPlatform for post-authorisation studies registered as EU trade mark →